Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis.

AIDS (London, England) - 24 Apr 2011

Fogel Jessica, Hoover Donald R, Sun Jin, Mofenson Lynne M, Fowler Mary G, Taylor Allan W, Kumwenda Newton, Taha Taha E, Eshleman Susan H

Abstract excerpt

BACKGROUND: In the Post Exposure Prophylaxis of Infants (PEPI)-Malawi trial, infants received up to 14 weeks of extended nevirapine (NVP) or extended NVP with zidovudine (NVP + ZDV) to prevent postnatal HIV transmission. We examined emergence and persistence of NVP resistance in HIV-infected infants who received these regimens prior to HIV diagnosis. METHODS: Infant plasma samples collected at 14 weeks of age...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to Infectious Disease Transmission, Vertical

Share to Malawi

Share to Nevirapine

Share to Viral Load

Share to Zidovudine

Source

Open in PubMed Open full text

Identifiers

PMID: 21487249
DOI: 10.1097/QAD.0b013e328344fedc
PMCID: PMC3261770

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis.PMID 21487249Read ↗

Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission.Semantic proximity Read ↗

Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission.Semantic proximity Read ↗

Impact of maternal and infant antiretroviral drug regimens on drug resistance in HIV-infected breastfeeding infants.Semantic proximity Read ↗

Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants.Semantic proximity Read ↗

Low-frequency nevirapine resistance at multiple sites may predict treatment failure in infants on nevirapine-based treatment.Semantic proximity Read ↗

Induction therapy with protease-inhibitors modifies the effect of nevirapine resistance on virologic response to nevirapine-based HAART in children.Semantic proximity Read ↗

Human Immunodeficiency Virus (HIV) Drug Resistance in African Infants and Young Children Newly Diagnosed With HIV: A Multicountry Analysis.Semantic proximity Read ↗

Frequent nevirapine resistance in infants infected by HIV-1 via breastfeeding while on nevirapine prophylaxis.Semantic proximity Read ↗

Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine.Semantic proximity Read ↗

HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine.Semantic proximity Read ↗

Next generation sequencing improves detection of drug resistance mutations in infants after PMTCT failure.Semantic proximity Read ↗

A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.